{"id":68573,"date":"2023-08-03T15:40:13","date_gmt":"2023-08-03T10:10:13","guid":{"rendered":"http:\/\/finservwealth.com\/three-ipos-to-hit-dalal-street-tomorrow-total-fund-raising-over-rs-1600-crore\/"},"modified":"2023-08-03T15:40:13","modified_gmt":"2023-08-03T10:10:13","slug":"three-ipos-to-hit-dalal-street-tomorrow-total-fund-raising-over-rs-1600-crore","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/three-ipos-to-hit-dalal-street-tomorrow-total-fund-raising-over-rs-1600-crore\/","title":{"rendered":"Three IPOs to hit Dalal Street tomorrow, total fund raising over Rs 1,600 crore"},"content":{"rendered":"<p> Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment.<\/p><div id=\"finse-3862808539\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/three-ipos-to-hit-dalal-street-tomorrow-total-fund-raising-over-rs-1600-crore_17152381.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment. Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/three-ipos-to-hit-dalal-street-tomorrow-total-fund-raising-over-rs-1600-crore_17152381.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/three-ipos-to-hit-dalal-street-tomorrow-total-fund-raising-over-rs-1600-crore_17152381.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment. Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/three-ipos-to-hit-dalal-street-tomorrow-total-fund-raising-over-rs-1600-crore_17152381.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-68573","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2022\/200x200\/I\/IPO-4_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/68573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=68573"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/68573\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=68573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=68573"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=68573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}